San Diego, CA
5:30 p.m.
Provoking Our Inner Stem Cells: Translating Stem Cell Research Breakthroughs into New Medicines
Boston, MA
Sunday, August 22 at 7 pm and Monday, August 23 at 8 pm: Poster Session, Hall C
Synthesis of novel osteogenic oxysterol activators of the Hedgehog signaling pathway
Brussels, Belgium
2:30 p.m. Presentation
Development of Small Molecule Therapeutics for Treating Endogenous Cells for Repair and Regeneration
Philadelphia, PA
9:30 a.m.
M&A panel session: Strategies to ensure a mutually beneficial partnership
1:10 p.m.
Panel session: A closer look at iPS cells – is this the future of stem cells research?
London, UK
11:30 a.m.
Company Presentation
New York City, NY
TBA
Chair of Health & Medicine Panel
San Diego, CA
Thursday, June 24, 3 p.m.
Company Presentation
San Francisco, CA
Presentations by our Scientific Founders and Scientific Advisory Board Members
Friday, June 18 Concurrent Session II (11:30 am -1:15 pm):
Track B: Hematopoietic Stem Cells: David T. Scadden, Massachusetts General Hospital
Track C: Small Molecule Screening for Stem Cell Regulation: Leonard I. Zon, Children’s Hospital Boston, and Sheng Ding, Scripps Research Institute
Saturday, June 19 Concurrent Session II (11:30 am -1:15 pm):
Track B: Muscle Stem Cells: Michael A. Rudnicki, Ottawa Health Research Institute, Canada
Napa, CA
10:15 am - 10:28 pm Presentation
Company Presentation
London, UK
11:55 am - 12:20 pm Presentation
Fate Therapeutics: a unique business model to translate stem cell research into new therapeutics
12:20 - 1:00 pm Panel
Current life science business models to develop a viable regenerative medicine model
5:30 - 6:10 am Panel
Commercial outlook on bringing soluble regulatory drugs to the market
Chicago, IL
10 - 11:30 am Panel Discussion
The Biotech Sandbox—Putting Aside Competition to Advance Transformational Technologies
San Diego, CA
6 - 7:30 p.m. Panel Discussion
Cambridge, MA
2:55 p.m. Presentation
Treating cancer: a stem cell company’s perspective
San Diego, California
Company Presentation
1:35 p.m. Presentation
The Industrialization of Advanced iPSC Technology for Drug Discovery
2 p.m. - 5:30 p.m. Featured Speaker
2:45 a.m. Presentation
The Industrialization of Advanced iPSC Technology for Drug Discovery
11:45 a.m. ‘Conversations with Experts’ Luncheon
3:00 p.m. Presentation
The Industrialization of Advanced iPSC Technology for Drug Discovery
11:30 a.m. Company Presentation
9:45 a.m. Panel Presentation
Today’s Deals: Generating Innovative Partnering Options
3:00 p.m. Panel Presentation
Commercialization of Stem Cells and International Partnerships, Alliances, and Acquisitions
6:00 p.m. Featured Company Presentation
Poster Presentation
12:00 p.m. Executive Panel
2:00 p.m. Panel Presentation
Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine
5:00 p.m. Company Presentation
9:35 a.m. Panel Presentation
iPS Panel of Experts